An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A new piece from the AAMC (Association of American Medical Colleges) lays out ten practical questions patients should ask their doctor if they’re considering peptide treatments. It’s not a study or a product launch. It’s guidance aimed at helping people talk with their clinicians about safety, evidence, costs and regulation before starting anything labeled a “peptide” therapy. Peptides are short chains of amino acids — think of them as tiny pieces of proteins. In medicine, some peptides are made to mimic natural signals in the body. For example, a licensed peptide drug can tell your brain or organs to change appetite, blood sugar, wound healing, or hormone release. But not every product called a peptide is the same. Some are approved medicines backed by trials; others are unregulated mixes sold online with unclear ingredients. The AAMC’s list is practical rather than new science. It suggests asking about evidence (has this been tested? in humans or just animals?), who will prescribe and monitor the therapy, expected benefits and how long they last, side effects and interactions with other drugs, dosing and administration, cost and insurance coverage, regulatory status, where the product comes from, what follow-up is planned, and alternatives. The piece emphasizes that many peptide treatments are still experimental or off-label (used in a way not officially approved) and that clinic practices vary widely. It doesn’t claim any one peptide works; instead it frames the conversation patients should have to judge claims. This matters because peptides are increasingly marketed directly to consumers for weight loss, anti-aging, athletic performance and more. A regular person thinking about one of these treatments should know whether there’s solid human evidence and safety oversight. The guidance helps patients avoid surprise bills, unproven therapies, and doctors or clinics that don’t plan proper monitoring. It also reminds people to weigh practical issues — like how often injections are needed or whether insurance will pay. Caveats are important. The AAMC guidance is not medical advice tailored to any one person. It warns that some peptide products sold online may be mislabeled, contaminated, or made at pharmacies with variable quality. Side effects depend on the specific peptide — from mild injection-site pain to more serious metabolic or hormonal effects — and long-term risks are often unknown for newer uses. People who are pregnant, breastfeeding, have serious medical conditions, or take multiple medications should be especially cautious and discuss risks with a trusted clinician. Bottom line: before trying a peptide treatment, bring questions about evidence, safety, source and monitoring to your doctor so you can make an informed decision.
Source: AAMC